Home
>
National Drug Code (NDC)
>
Dobutamine Hydrochloride in Dextrose
Dobutamine Hydrochloride in Dextrose - 0338-1075-02 - (Dobutamine Hydrochloride)
Drug Information of Dobutamine Hydrochloride in Dextrose
| Product NDC: | 0338-1075 |
| Proprietary Name: | Dobutamine Hydrochloride in Dextrose |
| Non Proprietary Name: | Dobutamine Hydrochloride |
| Active Ingredient(s): | 200 mg/100mL & nbsp; Dobutamine Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dobutamine Hydrochloride in Dextrose
| Product NDC: | 0338-1075 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020255 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19930927 |
Package Information of Dobutamine Hydrochloride in Dextrose
| Package NDC: | 0338-1075-02 |
| Package Description: | 250 mL in 1 BAG (0338-1075-02) |
NDC Information of Dobutamine Hydrochloride in Dextrose
| NDC Code | 0338-1075-02 |
| Proprietary Name | Dobutamine Hydrochloride in Dextrose |
| Package Description | 250 mL in 1 BAG (0338-1075-02) |
| Product NDC | 0338-1075 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dobutamine Hydrochloride |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19930927 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | DOBUTAMINE HYDROCHLORIDE |
| Strength Number | 200 |
| Strength Unit | mg/100mL |
| Pharmaceutical Classes | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |
